Navigation Links
Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments

8-year-old patient receives 'hidden scar' procedure; Pediatrics becomes 4th surgical specialty to benefit from single port surgery with RealHand HD


CUPERTINO, Calif., July 28 /PRNewswire/ -- Novare Surgical Systems announced the successful completion of the first pediatric single port splenectomy, using RealHand HD instruments. The patient, an 8-year-old boy from San Jose, CA, is doing very well and one day after his surgery was sitting up in his hospital bed playing games and prepping to go home the next day. The 'hidden scar' procedure was performed by Dr. Sanjeev Dutta at Stanford's Lucile Packard Children's Hospital and required only a single skin incision in the patient's belly button.

"It's called single port surgery," said Dr. Dutta, "and it's the next evolution in minimal access. And it's definitely stealth, since we're leaving no evidence a surgery even occurred. This pathway through the tummy is in the early stages of adoption in both kids and adults, but it's rapidly gaining acceptance," continued Dr. Dutta. "It definitely takes some dexterity and it helps that we now have surgery tools that mirror my actual hand movements." Dr. Dutta has no affiliation with Novare Surgical.

"My priority is doing what's best for the child," said Dr. Dutta. "Visible scars can be psychologically painful for children, so we want to reduce or eliminate them whenever we can. We're proving this type of surgery works, and we're thrilled to offer it."

"We are delighted with the expansion of single port surgery into pediatric minimally invasive procedures," said Joe Guido, Novare Surgical's Vice President of Marketing and Sales. "A significant pediatric patient population may soon realize the potential of reduced post operative pain, faster recovery and improved cosmetic results through this approach and we are proud that Novare's RealHand instruments are a key element in this process."

About RealHand(R) High Dexterity (HD) Instruments for Minimally Invasive Surgery

RealHand HD instruments are the very first full range of motion hand-held laparoscopic instruments. RealHand technology is designed to mirror the surgeon's hand direction with the added benefit of tactile feedback. As such, when the surgeon's hand moves in one direction, the instrument tip exactly follows.

Unlike standard laparoscopic instrumentation, RealHand offers complete 7 degrees of freedom of movement in a hand-held instrument and with no need for additional hardware. Moreover, RealHand will enable surgeons to perform more difficult maneuvers that otherwise cannot be completed with traditional rigid instruments. RealHand HD instruments make it easy to actively manipulate and complete tasks regardless of whether the instrument is positioned over, under, or around structures.

RealHand HD instruments provide for greater dexterity and control around critical structures and vasculature. The increase in range of motion is

leading the way in the development of new surgical approaches and techniques. RealHand instruments have received FDA 510(k) clearance.

About Novare Surgical Systems

Based in Cupertino, Calif., Novare Surgical Systems was originally founded in 1999. RealHand was developed entirely at Novare Surgical and represents a shift in the company's focus toward devices for minimally invasive surgery. For more information, visit the company's web site at

SOURCE Novare Surgical Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:11/24/2015)... The hope of bearing a ... IVF cycles. After failure of over 15 IVF cycles, ... all hopes that she would be able to conceive ever. But finally optimism prevailed as ... failure of over 15 IVF cycles. ... take one last attempt with Gaudium IVF Center in ...
(Date:11/24/2015)... CARLOS, Calif. , Nov. 24, 2015 ... a leader in non-invasive genetic testing and ... announced that it will present at the ... in New York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew ... the Company,s financial results, business activities and ...
(Date:11/24/2015)... 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the ... that the first patient has been enrolled in ESSA,s ... for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States and ... clinical trial, ESSA intends to demonstrate the safety, tolerability, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... 24, 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus ... in the United States grew 400 percent between 1999 and 2010, far more than ... 37 percent of all fatal drug overdoses. (1) , While oxycodone and the extended ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... Serenity Point ... a series of recent video interviews with some of the staff members at their ... the residential treatment facility, as well as some of the things that make their ...
(Date:11/24/2015)... ... 2015 , ... Chiropractic student Katie Benson received a $2,500 ... Park, Kansas. Benson, a fifth-trimester student in the university’s College of Chiropractic, accepted ... 16. , “Katie is very excited and greatly appreciative to receive the Standard ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading autism science and ... media and the generosity of people around the world. On December 1, supporters can ... give – and share the personal stories behind those gifts. , Just as ...
(Date:11/24/2015)... ... November 24, 2015 , ... World ... Fragrance by Marcelle, a cosmetic invention which offers a combination of natural essential ... in the US is worth $3 billion annually," says Scott Cooper, CEO and ...
Breaking Medicine News(10 mins):